"NEW YORK (Reuters) - Eli Lilly and Co. on Wednesday reported a fourth-quarter net loss on charges for restructuring and taxes related to the return of overseas profits, as sales of prescription drugs rose only slightly.
Global sales of schizophrenia treatment Zyprexa, Lilly's biggest product that has been hurt in the United States by concerns over side effects, fell further in the quarter..."
In case you were wondering, Zyprexa is repackaged Prozac. The patent ran out on Prozac, so they decided the same poison should be promoted differently as a solution for different "illnesses" and off they went with a newly patented drug, which was really a makeover of the old drug. But it's not working!
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment